A major obesity study by Eli Lilly and Company just linked serious weight loss to real knee pain relief; results Milwaukee Medical Weight Loss & MediSpa says feel familiar to patients using its GLP-1 and GIP programs.
Greenfield, WI, July 29, 2026 — Milwaukee Medical Weight Loss & MediSpa today announced expanded access to personalized metabolic therapies at its Greenfield clinic following published Phase 3 clinical trial results for investigational retatrutide. In Eli Lilly’s trials, participants achieved an average weight loss of 28.3% alongside a significant reduction in knee pain of over 70%, reinforcing the clinic’s position as a regional leader in advanced obesity medicine.
The announcement comes as clinical research continues to redefine modern weight management. Traditional strategies often fail to deliver sustainable results, leaving millions of Americans navigating persistent joint pain and weight gain. Targeted hormonal therapies address these challenges by treating obesity as a complex metabolic condition rather than a failure of willpower, delivering measurable improvements in both body composition and joint mobility.
“Most people who walk through our doors aren’t thinking about a clinical trial,” said Dr. Sandeep Ramanujam, M.D., Medical Director at Milwaukee Medical Weight Loss & MediSpa. “They’re thinking about standing up from a chair without their knee catching. So when a study this size shows weight and pain moving in the same direction, that tells us we’re heading the right way.”
To meet growing regional demand, Milwaukee Medical Weight Loss & MediSpa provides physician-supervised programs utilizing current FDA-approved GLP-1 and GIP receptor agonists, including Semaglutide and Tirzepatide.
Semaglutide therapy mimics natural GLP-1 hormones to slow gastric emptying, curb cravings, and regulate blood sugar. Tirzepatide treatments provide a dual-action mechanism activating both GLP-1 and GIP receptors, optimizing insulin sensitivity and promoting up to 22% greater weight loss than single-hormone treatments.
Every protocol includes comprehensive medical consultations, custom dosing, routine health monitoring, and personalized nutritional and lifestyle coaching. The clinic also offers virtual appointments, allowing new and existing patients searching for reliable medical weight loss in Milwaukee to access expert care remotely.
“We’ve never wanted to just chase a number on a chart,” said Angela Schaefer, Clinic Manager at Milwaukee Medical Weight Loss & MediSpa. “Weight and mobility go hand in hand, and that’s always been part of how we treat people here.”
More retatrutide data is expected, and the clinic plans to keep watching while continuing to care for patients with options already proven today. For anyone who’s ever wondered whether their weight and their knees are more connected than they’ve been told, that conversation can start by scheduling a virtual or in-person consultation at milwaukeemedicalweightlossmedispa.com or (414) 616-3535.
About Milwaukee Medical Weight Loss & MediSpa:
Milwaukee Medical Weight Loss & MediSpa is a locally owned and operated clinic that has served the greater Milwaukee area since 2013. The practice offers personalized GLP-1 and GIP weight loss therapy, custom peptide protocols, and non-surgical medspa treatments, including Botox, dermal fillers, and laser hair removal.
Media Contact:
Organization: Milwaukee Medical Weight Loss & MediSpa
Contact Person: Angela Schaefer
Phone Number: (414) 616-3535
Address: 8575 W Forest Home Ave #170, Greenfield, WI 53228
Website: https://milwaukeemedicalweightlossmedispa.com/
